NASDAQ
Achilles Therapeutics plc (ACHL) has a current ratio of 8.57x as of Monday, May 25, 2026. This represents a 46.31% decrease compared to its 12-month average of 15.96x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.